株式会社極東書店トップ > 商品一覧 > Metabolism and Epigenetic Regulation: Implications in Cancer. 2022 ed.
商品詳細
Metabolism and Epigenetic Regulation: Implications in Cancer. 2022 ed.
・ISBN 978-3-031-07633-6 hard EUR 229.99
¥61,475.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Kundu, Tapas Kumar / Das, Chandrima (eds.), |
|---|---|
| シリーズ | (Subcellular Biochemistry) |
| 出版社 | (Springer International Publishing AG, SZ) |
| 出版年月 | 2022 |
| ページ数 | 620 pp. |
| 言語 | ENG |
| ニュース番号 | <A02-71810> |
解説
Metabolic programs of individuals are key determinants for disease susceptibility and immune response. This book, edited by experts in the field, summarizes epigenetic signaling pathways that regulate metabolic programs associated with cancer and cancer-related secondary diseases.
The first part of the book highlights key metabolic pathways that are implicated in cancer and provides a comprehensive overview on the carbohydrate, protein, lipid, amino- and nucleic acid metabolic pathways that are deregulated in cancer. Special attention is paid to the altered tumor micro-environment that is influenced by the metabolic milieu. Furthermore, the fundamental relationship between the cellular metabolic environment and cell death-mediated autophagy is discussed.
The second part of the book covers our understanding of the fundamental epigenetic regulations that are implicated in controlling the metabolic programs in cancer cells. Many aspects of epigenetic regulation of non-coding RNAs as well as DNA/RNA methylation, which influencing metabolic homeostasis in cancer, are discussed in detail. Special emphasis is placed on the epigenetic regulation of the amino acid, glucose/carbohydrate metabolism and epigenetic regulation during hypoxia and its connection to cancer.
Last but not least, the third part of the book covers small molecule modulators of histone modifying enzymes, which can be used as therapeutic tools. The readers learn about the cross-talk between epigenetics and immunometabolims, as well as the epigenetic regulation of oncometabolites to combat cancer.
Given its scope, the book will appeal to a broad readership interested in epigenetic, cancer and metabolic research.